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Objective: To compare outcomes between children (<18 yrs) and adults undergoing total thyroidectomy for
Graves’ disease (GD) at a high volume, multidisciplinary thyroid center.
Summary of background data: Reported complication rates for children undergoing surgery for Graves’ disease
are worse than for adults.
Methods: 100 consecutive patients (32 children; 68 adults) who underwent total thyroidectomy for Graves’ disease
(GD) by a high-volume endocrine surgery team from were compared.
Results: The mean patient age was 9.7 yrs (range 3.4-17.9 yrs) in children versus 44.9 yrs (range 18.4-84.2 yrs) in
adults. Operative times were longer in children (2.18 ± 0.08 hrs) than in adults (1.66 ± 0.03 hrs) (p = 0.003). Pediatric
thyroid specimens averaged 38.6.0 ± 8.9 gm (range: 9–293 gm) and adult thyroid specimens averaged 48.0 ± 6.4 gm
(range: 6.6-203 gm) (p = 0.34). Thyroid to body weight ratios were greater in children (0.94 ± 0.11 gm/kg) than
adults (0.67 ± 0.8 gm/kg) (p = 0.05). In all patients, the hyperthyroid state resolved after surgery. There was no
operative mortality, recurrence, or permanent hypoparathyroidism. Transient post-operative hypocalcemia requiring
calcium infusion was greater in children than adults (6/32 vs. 1/68; p = 0.004). Transient recurrent laryngeal nerve
dysfunction occurred in two children and in no adults (p = 0.32). Postoperative hematoma occurred in two adults
and in no children (p = 0.46). The length of stay was longer for children (1.41 ± 0.12 days) than for adults (1.03 ±0.03
days) (p = 0.004).
Conclusion: Surgical management of GD is technically more challenging in children as evidenced by longer
operative times. Whereas temporary hypocalcemia occurs more commonly in children than adults, the risks of
major complications including disease recurrence, permanent hypoparathyroidism, recurrent laryngeal nerve injury,
or neck hematoma were indistinguishable. These data suggest that excellent and equivalent outcomes can be
achieved for GD surgery in children and adults when care is rendered by a high volume, endocrine surgery team.
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Patients requiring IV Calcium 1 6 0.004*
RLN Injuries 0 1 0.32*
Hematomas 2 0 0.46*
Incidental Cancers 12 1 0.01*
Thyroid mass (g)/Body mass (kg) 0.67 0.94 0.05†
Operative Time (hour:min) 1:37 2:09 0.001†
Inpatient Post Operative Days 1.03 1.41 0.004†
* - Fisher's Exact test.
† - Student's t-test.
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A recent analysis of the Healthcare Cost and Utilization
Project National Inpatient Sample (HCUP-NIS) database
evaluated outcomes in children undergoing thyroid and
parathyroid surgery [1]. Pediatric patients were observed
to have higher complication rates than those reported
for adults [1,2]. Pediatric complication rates were lower
when the surgery was performed by a high volume endo-
crine surgeons, defined as performing >30 cases per year
[3-5], but remained higher than those reported for adults
[1,3,6].
We hypothesized that an endocrine surgical team con-
sisting of a high volume endocrine surgeon, a pediatric
surgeon, a pediatric endocrinologist and an experienced
endocrine surgery nurse could attenuate the outcome
gap between pediatric and adult surgical patients. To
evaluate the outcome of this approach, we compared the
outcomes of 100 consecutive pediatric and adult patients
who underwent thyroidectomy for Graves’ disease (GD)
at a single institution by high volume adult and pediatric
endocrine surgery team.
Methods
The Yale Pediatric Thyroid Center is a multidisciplinary
team composed of a high volume endocrine surgeon
(greater than 200 thyroidectomies/year), a pediatric sur-
geon, pediatric endocrinologists, pediatric anesthesiolo-
gists and experienced nursing and supportive staff. The
Yale Pediatric Thyroid Center sees about 300 pediatric
patients per year with thyroid disorders and approxi-
mately 30 pediatric patients undergo thyroid surgery an-
nually. All pediatric patients who underwent total
thyroidectomy for GD as part of the Yale Pediatric Thy-
roid Center between June 2002 and November 2010
were entered into a database. Adult patients operated on
over the same period were identified, as well from CPT
codes (60240, 60252). All pediatric procedures were per-
formed by both attending surgeons. All but one patient
were treated pre-operatively with supersaturated potas-
sium iodide (SSKI) for at least 5 days prior to surgery.
The one pediatric patient not treated fully with SSKI
developed an allergic reaction after two doses and the
medication was discontinued.
Twenty pediatric patients were treated with 0.5 mcg of
calcitriol twice daily for 3 days before surgery. Post-
operatively the calcitriol was weaned over 15 days (0.5 mcg
bid × 5 days; then 0.5 mcg qd × 5 days; then 0.5 mcg qod
for 5 days).
In all cases either a total or bilateral near-total thyroi-
dectomy was performed. A total thyroidectomy was
defined as a complete resection of the thyroid gland via
an extracapsular dissection [7,8]. If it is was determined
intraoperatively that a complete extracapsular dissection
would likely result in irreversible damage to either therecurrent laryngeal nerve (RLN) or parathyroid gland(s),
the capsule was entered and a miniscule amount of thy-
roid tissue was left in situ to avoid injury to either the
RLNs or parathyroid glands, a procedure referred to as a
near-total thyroidectomy [7,8].
All patients were admitted post-operatively. Serum cal-
cium levels were measured every 4 to 8 hrs after surgery
in the pediatric patients and in all patients on the morn-
ing of post-operative day one. Intravenous calcium glu-
conate therapy was administered if serum calcium levels
(corrected for total protein) measured <7.5 mg/dL with-
out symptoms of hypocalcemia or measured <8.0 mg/dL
in the presence of symptomatic hypocalcaemia (e.g. hand
parasthesias, perioral numbness, muscle cramps, the
presence of a Chvostek’s sign).
Pre-operative demographics, comorbidities and medi-
cations were recorded. Operative details including
detailed contemporaneous operative illustrations, post-
operative course, serum calcium levels and operative
pathology were recorded. Permanent recurrent laryngeal
nerve (RLN) injury, hematoma and permanent hypo-
parathyroidism were classified as major complications.
Transient hypocalcemia requiring intravenous calcium
infusion and transient RLN neuropraxia were considered
to be minor complications.
Statistical analysis was performed using Students’t-test
and Fisher’s exact test as appropriate. Statistical signifi-
cance was determined when p < 0.05. Values shown are
mean ± standard deviation.
The Yale Human Investigations Committee approved
this study.Results
Thirty two children and 68 adults underwent total or
near-total thyroidectomy. The clinical characteristics of
the patients are described in Table 1. The mean age at
time of surgery was 9.7 years (range 3.4-17.9 yrs) for
children and 44.9 years (range 18.4-84.2 yrs) for adults.
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the adult patients.
Pediatric procedures required longer operative time than
those of adults (1.18 ± 0.08 hrs vs. 2.09 ± 0.03 hrs, p = 0.003).
Pediatric thyroid specimens averaged 38.6.0 ± 8.9 gm (range
9–293 gm) (p = 0.34) and adult thyroid specimens averaged
48.0 ± 6.4 gm (range 6.6-203 gm) (p = 0.34). When the thyr-
oidectomy specimen weight was considered in relation to
that of the patient, the pediatric patients had larger glands
per kilogram of body mass as compared to the adults
(0.94 ± 0.11 gm/kg vs. 0.66 ± 0.07 gm/kg, p = 0.05)
Pathological analysis of the operative specimens revealed
occult malignancy in one of the 32 pediatric patients and
in 12 of the 68 adult patients (p = 0.03). The one pediatric
patient had a papillary microcarcinoma of 0.4 cm in great-
est diameter confined to the thyroid capsule. In the adults,
10 of 12 malignancies represented papillary microcarcino-
mas that were less than 0.3 cm in greatest diameter. One
case was a multifocal papillary carcinoma that included a
papillary carcinoma that was 2.5 cm in greatest diameter.
There was one Hürthle cell adenoma in an adult patient.
Pediatric patients were more likely to require postopera-
tive intravenous calcium infusion than adults (18.0% vs.
1.4%, p = 0.004). Pediatric patients required a longer
length of stay than adults (1.41 ± 0.12 vs. 1.03 ±0.03 days,
p = 0.004) reflecting the greater need for calcium
infusions.
When preoperative calcitriol was not given 50% of
pediatric patients required calcium infusion with a mean
duration of infusion of 1.5 ±0.3 days. When calcitriol
was given, 16% of patients required calcium infusion
with a mean duration of infusion of 1.25 days (p 0.02 vs.
no caclitriol).
There was one case of transient RLN neuropraxia in a
child that recovered within 6 months after surgery. One
child sustained a RLN transaction during surgery that
was recognized and repaired during the initial proced-
ure. Long term follow-up revealed that RLN function
was restored as evidenced by bilateral vocal cord mobil-
ity 12 months after surgery. There were no RLN injuries
in the adults.
There were 2 post-operative hematomas in the adult
group requiring operative exploration and none in the
pediatric group (p = 0.46). There was no operative or
perioperative mortality, and no cases of permanent
hypoparathyroidism. Follow up data indicated no recur-
rences of hyperthyroidism in either children or adults
over up to a maximal follow-up period of 8 years. The
overall rates of major complications were indistinguish-
able comparing children and adults.
Discussion
Graves’ disease is rare in children with a prevalence of 1
in 10,000 [9,10]. Because only a minority of pediatricpatients achieve remission [11-14], the majority of
patients will require either radioactive iodine or surgery
[4,9]. Our observations support the notion that in the
hands of high volume thyroid surgeons, thyroidectomy
is an appropriate treatment option for pediatric patients.
To date the largest series detailing the surgical treat-
ment of GD in children is from the Mayo Clinic [15].
Seventy-eight pediatric patients, ages 3.1 to 17.9 years,
with GD underwent surgical treatment [15]. Sixty
patients (77%) underwent total or near-total thyroidect-
omy; 18 patients (23%) underwent bilateral subtotal
thyroidectomy [15]. When a sub-total thyroidectomy is
performed, a small amount of thyroid tissue is left be-
hind in the region of the RLN or parathyroid glands in
the hope of minimizing risks of RLN injury or hypopara-
thyroidism [8].
In the Mayo Clinic series, no RLN injuries, hemato-
mas, nor instances of permanent hypoparathyroidism
were reported [15]. One patient (1%) developed transient
RLN neuropraxia, and 5 patients (6%) had transient
hypoparathyroidism [15]. Five microcarcinomas (6%)
were identified in the pathological specimens [15]. Of
note, 4 of the 18 patients (22%) who underwent bilateral
subtotal thyroidectomy experienced recurrence of their
hyperthyroidism [15].
Recognizing the high recurrence rate associated with
subtotal thyroidectomy, we adopted an aggressive surgi-
cal approach for the management of GD in children and
adults by performing total or near-total thyroidectomies
in all patients. Supporting the utility of our approach in
curing the disease, no patient in our series experienced
relapse of their GD.
HCUP-NIS data show that pediatric patients suffer
complications more frequently following thyroidectomy
than adults (9.3% vs. 6.1%, p < 0.01) [1,2]. In our cohort,
we observed transient hypocalcemia, presumable due to
transient hypoparathyroidism, as the most common
minor complication in pediatric patients. However, with
preoperative calcitriol therapy, the need for post-operative
calcium infusions was reduced from 50% to 16% and the
duration of intravenous calcium infusion was shortened
by more than 50%.
RLN injury was observed in two of the children in our
cohort. In one child, a soft voice was observed shortly
after surgery, and direct laryngoscopy performed two
months after surgery revealed unilateral vocal cord par-
esis. At six months after surgery, there was normal bilat-
eral vocal cord function and the voice was normal.
One child, 4 years of age, had transection of one RLN
during surgery that was immediately recognized and
repaired. At 6 months after surgery, unilateral vocal cord
paresis was observed by direct laryngoscopy. At 18
months after surgery, direct laryngoscopy revealed bilat-
eral vocal cord movement and the voice was normal. Of
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could not be treated preoperatively with SSKI due to an
anaphylactic reaction to the medication.
It is interesting that occult malignancy was seen in 12
of 68 adult patients and in 1 of 32 pediatric patients.
Ten of the 12 malignancies seen in adults were unifocal
papillary microcarcinomas, and one case was a multi-
focal papillary carcinoma that was 2.5 cm in the greatest
diameter. A papillary microcarcinoma of 0.4 cm con-
fined to the thyroid capsule was seen in one pediatric
patient. These observations highlight the need for clini-
cians to obtain sonographic imaging of the thyroid gland
if asymmetry or gland size change is noted in the setting
of GD. Should nodules be observed, they should be eval-
uated per recent guidelines [16].
The observation of microcarcinomas in the setting of
GD, which will be difficult to identify by preoperative
ultrasound, should not be construed as an argument to in
favor of surgery over radioactive iodine in the definitive
treatment of GD. If GD patients with microcarcinomas
are treated with recommended activities of radioactive
iodine that are intended to ablate thyroid tissue [4,17,18],
it is anticipated that microcarcinomas will be destroyed
along with normal thyroid tissue. Support for this notion
come from data from the Thyrotoxicosis Study Group
follow-up data showing that rates of differentiated thyroid
cancer in patients with GD are substantially lower in those
treated with radioactive iodine or surgery than in indivi-
duals treated with antithyroid medications alone who
underwent spontaneous remission [19].
Overall, we demonstrate that total or near-total
pediatric thyroidectomy can be performed safely in
experienced hands and is not associated with GD recur-
rence. A multidisciplinary team consisting of a high vol-
ume endocrine surgeon, a pediatric surgeon, pediatric
endocrinologists, pediatric anesthesiologists, and experi-
enced endocrine nurses can achieve excellent outcomes
with very low complication rates. These observations
support recent recommendations that children and
adults requiring surgery for GD should be operated on
by high volume endocrine surgical teams [4,5].Competing interests
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